Jul 9, 2008 by Brian LawlerViroPharma Makes Its CaseAre its plans for an end-around to block competition coming to a close?
Jul 9, 2008 by Brian LawlerPredicting More Good News From InvitrogenInvitrogen gets a positive review from the FDA for one of its tests.
Jul 8, 2008 by Brian LawlerBlockbuster Drugs Bound for Extinction?One of the biggest classes of prescription drugs faces tougher FDA standards.
Jul 3, 2008 by Brian LawlerCelgene Savors the SchadenfreudeBad news for a rival is a bonanza for the drugmaker.
Jul 3, 2008 by Brian LawlerA Cubist MasterstrokeThe one-drug wonder now becomes a marketer of two compounds.
Jul 2, 2008 by Brian LawlerDURECT's Intriguing Little OrphanAn exciting pain drug inches onward in development.
Jul 2, 2008 by Brian LawlerA Hearteningly Cheap Rule BreakerSometimes, even a growth stock goes on sale.
Jul 1, 2008 by Brian LawlerMyriad's Small Billion-Dollar Loss Was it a big defeat for Myriad's lead pipeline drug candidate?
Jul 1, 2008 by Brian LawlerExelixis and Glaxo Begin Their GoodbyesSometimes, even the best couples break up.
Jul 1, 2008 by Brian LawlerFDA News Gives Glaxo a Glimmer of HopeApproval is delayed, but new studies won't be needed for Cervarix.
Jun 27, 2008 by Brian LawlerThis Drug Market Is BoomingHere's your chance to invest in a category experiencing double-digit growth.
Jun 27, 2008 by Brian LawlerMore Cash for CVTA recently approved drug plumps up the pharmaceutical's coffers.
Jun 27, 2008 by Brian LawlerVanda's Drug Draws a YawnMixed results in the clinic don't spell blockbuster potential.
Jun 27, 2008 by Brian LawlerDrugmakers: Not So Recession-Proof?Pharmaceuticals and biopharmaceuticals are in the red for 2008.
Jun 27, 2008 by Brian LawlerDifficult Obstacles for SciClone Is this drugmaker a day late and a dollar short?
Jun 26, 2008 by Brian LawlerGauging Glaxo's Vaccine ValueSurprise! The FDA actually approves a new medicine without delay.
Jun 25, 2008 by Brian LawlerWhy the Lilly Delay, FDA?A government review of the company's top drug candidate gets pushed back.
Jun 23, 2008 by Brian LawlerSanofi Goes East to Find Growth Sanofi bests a rival for control of a Czech drugmkaer.
